• Molecular NameIvermectin
  • Synonym22,23-Dihydroxy-avermectin B; 22,23-Dihyroavermectin B1; 5-O-demethyl-22,23-dihydro-avermectin A1a
  • Weight875.106
  • Drugbank_IDDB00602
  • ACS_NO70288-86-7
  • Show 3D model
  • LogP (experiment)N/A
  • LogP (predicted, AB/LogP v2.0)6.97
  • pkaN/A
  • LogD (pH=7, predicted)6.97
  • Solubility (experiment)N/A
  • LogS (predicted, ACD/Labs)(ph=7)-3.67
  • LogSw (predicted, AB/LogsW2.0)0.0
  • Sw (mg/ml) (predicted, ACD/Labs)0.19
  • No.of HBond Donors3
  • No.of HBond Acceptors14
  • No.of Rotatable Bonds8
  • TPSA170.06
  • StatusFDA approved
  • AdministrationN/A
  • PharmacologyA broad-spectrum antiparasitic medication.
  • Absorption_value60.0
  • Absorption (description)N/A
  • Caco_2N/A
  • BioavailabilityN/A
  • Protein binding93.1
  • Volume of distribution (VD)9.91 L/kg
  • Blood/Plasma Partitioning ratio (D_blood)N/A
  • Metabollsmliver; CYP450
  • Half life56.5 h
  • Excretionfeces; <1% urine
  • Urinary Excretion<1
  • Clerance2.06 ml/min/kg
  • ToxicityN/A
  • LD50 (rat)N/A
  • LD50 (mouse)N/A